Drugs for Neglected Diseases initiative (DNDi) Revenue
Research Services • 
Le Petit-Saconnex, Geneva, Switzerland • 201-500 Employees
Drugs for Neglected Diseases initiative (DNDi) revenue & valuation
| Annual revenue | $7,927,885 |
| Revenue per employee | $19,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Research Services industry and current estimated revenues | $25,400,000 |
| Total funding | No funding |
Key Contacts at Drugs for Neglected Diseases initiative (DNDi)
Dr Kavita Singh
Asia Continental Lead And Director, South Asia
Dr Luis Pizarro
Executive Director
Delali Attiogbe
Regional Executive Director, Dndi North America
Charles Mowbray
Discovery Director
Eric Stobbaerts
International Development Director
Stephen Robinson
Pharmaceutical Development Director
Anderson Leal
Hr And Organization Director
Thi Hanh Cao
Director Of External Relations And Communication
Rudi Paye
Director Of Strategy And Operations
Chirac Bulanga
Director Drc Regional Office
Company overview
| Headquarters | 15 Chemin Camille-Vidart, Geneva, 1202, CH |
| Phone number | +4116466168683 |
| Website | |
| NAICS | 5417 |
| SIC | 283 |
| Keywords | Research, Not-For-Profit, Drug Development, R&D, Medicine, Dengue, Neglected Tropical Diseases, Open Innovation, Hepatitis C, Malaria, Neglected Diseases, Leishmaniasis, Chagas Disease, Filarial Diseases, Human African Trypanosomiasis, Paediatric Hiv, Mycetoma, Ntds |
| Founded | 2003 |
| Employees | 201-500 |
| Socials |
Drugs for Neglected Diseases initiative (DNDi) Email Formats
Drugs for Neglected Diseases initiative (DNDi) uses 5 email formats. The most common is {first initial}{last name} (e.g., jdoe@dndi.org), used 48.9% of the time.
| Format | Example | Percentage |
|---|---|---|
{first initial}{last name} | jdoe@dndi.org | 48.9% |
{first name}{last name} | johndoe@dndi.org | 41.7% |
{last name}{last name} | doedoe@dndi.org | 4.4% |
{2char} | {2char}@dndi.org | 1.1% |
{last name} | doe@dndi.org | 1.1% |
About Drugs for Neglected Diseases initiative (DNDi)
The Drugs for Neglected Diseasesinitiative (DNDi) is an international, not-for-profit research and development organization. We discover, develop, and deliver treatments for neglected patients around the world. Our treatments are affordable and patient-friendly – and have already saved millions of lives. We are researching new treatments for people living with Chagas disease, sleeping sickness (human African trypanosomiasis), leishmaniasis, filarial infections, mycetoma, paediatric HIV, hepatitis C, and dengue. Together with our partners, we are working on over 40 projects, including more than 20 new chemical entities. We are also running over 20 clinical trials. When the medical humanitarian organization Médecins Sans Frontières (MSF) won the Nobel Peace Prize in 1999, they dedicated a portion of the award to addressing this fatal imbalance and exploring a new, alternative, not-for-profit model for developing drugs for neglected patients. As a result in 2003, MSF, the World Health Organization, and five international research institutions founded DNDi.
Employees by Management Level
Total employees: 201-500
Seniority
Employees
Employees by Department
Drugs for Neglected Diseases initiative (DNDi) has 158 employees across 13 departments.
Departments
Number of employees
Drugs for Neglected Diseases initiative (DNDi) Tech Stack
Discover the technologies and tools that power Drugs for Neglected Diseases initiative (DNDi)'s digital infrastructure, from frameworks to analytics platforms.
Performance
JavaScript libraries
JavaScript libraries
Maps
Page builders
Web servers
JavaScript libraries
Advertising
Caching
Programming languages
Security
Saudi Arabia
Australia
Germany
Frequently asked questions
4.8
40,000 users
